Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia.

Saved in:
Bibliographic Details
Title: Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia.
Authors: Salles G; Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard, INSERM 1052, Pierre Bénite, France. gilles.salles@chu-lyon.fr., Bachy E; Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard, INSERM 1052, Pierre Bénite, France., Smolej L; 4th Department of Internal Medicine, Hematology, University Hospital and Faculty of Medicine, Charles University, Hradec Králové, Czech Republic., Simkovic M; 4th Department of Internal Medicine, Hematology, University Hospital and Faculty of Medicine, Charles University, Hradec Králové, Czech Republic., Baseggio L; Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard, INSERM 1052, Pierre Bénite, France., Panovska A; Department of Internal Medicine, Hematology and Oncology, University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Besson H; 's-Hertogenbosch, The Netherlands., Healy N; Janssen Sciences, Dublin, Ireland., Garside J; Janssen-Cilag Limited, High Wycombe, UK., Iraqi W; Janssen Pharmaceuticals, Paris, France., Diels J; Janssen Pharmaceutica NV, Beerse, Belgium., Pick-Lauer C; Janssen-Cilag GmbH, Neuss, Germany., Spacek M; 1st Department of Medicine, Department of Hematology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic., Urbanova R; University Hospital Olomouc, Olomouc, Czech Republic., Lysak D; University Hospital Pilsen, Pilsen, Czech Republic., Hermans R; IQVIA Real-World Insight Solutions, London, UK., Lundbom J; IQVIA Real-World Insight Solutions, London, UK., Callet-Bauchu E; Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard, INSERM 1052, Pierre Bénite, France., Doubek M; Department of Internal Medicine, Hematology and Oncology, University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; CEITEC, Masaryk University, Brno, Czech Republic.
Source: Annals of hematology [Ann Hematol] 2019 Dec; Vol. 98 (12), pp. 2749-2760. Date of Electronic Publication: 2019 Nov 19.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31745601
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Salles+G%22">Salles G</searchLink>; Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard, INSERM 1052, Pierre Bénite, France. gilles.salles@chu-lyon.fr.<br /><searchLink fieldCode="AU" term="%22Bachy+E%22">Bachy E</searchLink>; Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard, INSERM 1052, Pierre Bénite, France.<br /><searchLink fieldCode="AU" term="%22Smolej+L%22">Smolej L</searchLink>; 4th Department of Internal Medicine, Hematology, University Hospital and Faculty of Medicine, Charles University, Hradec Králové, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Simkovic+M%22">Simkovic M</searchLink>; 4th Department of Internal Medicine, Hematology, University Hospital and Faculty of Medicine, Charles University, Hradec Králové, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Baseggio+L%22">Baseggio L</searchLink>; Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard, INSERM 1052, Pierre Bénite, France.<br /><searchLink fieldCode="AU" term="%22Panovska+A%22">Panovska A</searchLink>; Department of Internal Medicine, Hematology and Oncology, University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Besson+H%22">Besson H</searchLink>; 's-Hertogenbosch, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Healy+N%22">Healy N</searchLink>; Janssen Sciences, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Garside+J%22">Garside J</searchLink>; Janssen-Cilag Limited, High Wycombe, UK.<br /><searchLink fieldCode="AU" term="%22Iraqi+W%22">Iraqi W</searchLink>; Janssen Pharmaceuticals, Paris, France.<br /><searchLink fieldCode="AU" term="%22Diels+J%22">Diels J</searchLink>; Janssen Pharmaceutica NV, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Pick-Lauer+C%22">Pick-Lauer C</searchLink>; Janssen-Cilag GmbH, Neuss, Germany.<br /><searchLink fieldCode="AU" term="%22Spacek+M%22">Spacek M</searchLink>; 1st Department of Medicine, Department of Hematology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Urbanova+R%22">Urbanova R</searchLink>; University Hospital Olomouc, Olomouc, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Lysak+D%22">Lysak D</searchLink>; University Hospital Pilsen, Pilsen, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Hermans+R%22">Hermans R</searchLink>; IQVIA Real-World Insight Solutions, London, UK.<br /><searchLink fieldCode="AU" term="%22Lundbom+J%22">Lundbom J</searchLink>; IQVIA Real-World Insight Solutions, London, UK.<br /><searchLink fieldCode="AU" term="%22Callet-Bauchu+E%22">Callet-Bauchu E</searchLink>; Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard, INSERM 1052, Pierre Bénite, France.<br /><searchLink fieldCode="AU" term="%22Doubek+M%22">Doubek M</searchLink>; Department of Internal Medicine, Hematology and Oncology, University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; CEITEC, Masaryk University, Brno, Czech Republic.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229107334%22">Annals of hematology</searchLink> [Ann Hematol] 2019 Dec; Vol. 98 (12), pp. 2749-2760. <i>Date of Electronic Publication: </i>2019 Nov 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9107334 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0584 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209395555%22">09395555 </searchLink><i>NLM ISO Abbreviation: </i>Ann Hematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31745601
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00277-019-03830-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2749
    Titles:
      – TitleFull: Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Salles G
      – PersonEntity:
          Name:
            NameFull: Bachy E
      – PersonEntity:
          Name:
            NameFull: Smolej L
      – PersonEntity:
          Name:
            NameFull: Simkovic M
      – PersonEntity:
          Name:
            NameFull: Baseggio L
      – PersonEntity:
          Name:
            NameFull: Panovska A
      – PersonEntity:
          Name:
            NameFull: Besson H
      – PersonEntity:
          Name:
            NameFull: Healy N
      – PersonEntity:
          Name:
            NameFull: Garside J
      – PersonEntity:
          Name:
            NameFull: Iraqi W
      – PersonEntity:
          Name:
            NameFull: Diels J
      – PersonEntity:
          Name:
            NameFull: Pick-Lauer C
      – PersonEntity:
          Name:
            NameFull: Spacek M
      – PersonEntity:
          Name:
            NameFull: Urbanova R
      – PersonEntity:
          Name:
            NameFull: Lysak D
      – PersonEntity:
          Name:
            NameFull: Hermans R
      – PersonEntity:
          Name:
            NameFull: Lundbom J
      – PersonEntity:
          Name:
            NameFull: Callet-Bauchu E
      – PersonEntity:
          Name:
            NameFull: Doubek M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2019 Dec
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0584
          Numbering:
            – Type: volume
              Value: 98
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Annals of hematology
              Type: main
ResultId 1